Literature DB >> 32813028

Accuracy of MRI for nodal restaging in rectal cancer: a retrospective study of 166 cases.

Sayali Pangarkar1,2, Kunal Mistry1,2, Amit Choudhari1,2, Vasundhara Smriti1,2, Ankita Ahuja1,2, Aparna Katdare1,2, Reena Engineer2,3, Vikas Ostwal2,4, Mukta Ramadwar2,5, Avanish Saklani2,6, Akshay D Baheti7,8.   

Abstract

AIM: Assessing metastatic mesorectal nodal involvement is a challenge in rectal cancer, especially in the post chemoradiation setting. We aim to assess the accuracy of MRI for nodal restaging and the validity of SAR criteria (≥ 5 mm size being metastatic).
MATERIALS AND METHODS: This was an IRB-approved retrospective study of 166 patients with locally advanced rectal cancers, operated after neoadjuvant treatment. Two dedicated oncoradiologists reviewed the 166 post-chemoradiation presurgical MRIs in consensus. Nodal size and morphology (shape, margins, and signal intensity) were noted. The most accurate cut-off for size for predicting positive pN status was determined using the Youden index.
RESULTS: MRI understaged 30/166 (18%) and overstaged 40/166 (24%) patients using the SAR criteria. The most accurate cut-off for node size was 5.5 mm, with a sensitivity of 75%, specificity of 60.2%, PPV of 40.7%, NPV of 86.9% (95% CI:78-92.5%), accuracy of 64.2%, and area under the curve (AUC) 0.657 (95% CI-0.524-0.79). Morphological characteristics were not significant to determine involvement, with positive nodes including 42% of round and 31% of oval nodes, 40% of heterogeneous and 45% of homogeneous nodes, and 31% irregularly marginated and 46% nodes with regular margins being positive on pathology. MRI was accurate in predicting pathology for mucinous nodes in 9/29 (31%) cases. Seven cases which were yN2 on MRI and yN0 on pathology demonstrated mucinous changes on MRI and had acellular mucin on histopathology.
CONCLUSIONS: MRI has good negative predictive value, poor positive predictive value and moderate accuracy in nodal restaging. The cut-off of 5.5 mm demonstrated in our study is close to the SAR cut-off of 5 mm in the post-treatment setting. MRI accuracy is lower in patients with mucinous nodes.

Entities:  

Mesh:

Year:  2020        PMID: 32813028     DOI: 10.1007/s00261-020-02708-y

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  20 in total

1.  Identification of extracapsular invasion of the metastatic lymph nodes as a useful prognostic sign in patients with resectable colorectal cancer.

Authors:  K Komuta; S Okudaira; M Haraguchi; J Furui; T Kanematsu
Journal:  Dis Colon Rectum       Date:  2001-12       Impact factor: 4.585

2.  Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis.

Authors:  Eisar Al-Sukhni; Laurent Milot; Mark Fruitman; Joseph Beyene; J Charles Victor; Selina Schmocker; Gina Brown; Robin McLeod; Erin Kennedy
Journal:  Ann Surg Oncol       Date:  2012-01-20       Impact factor: 5.344

Review 3.  Neoadjuvant and adjuvant therapy for rectal cancer.

Authors:  J Pablo Arnoletti; Kirby I Bland
Journal:  Surg Oncol Clin N Am       Date:  2006-01       Impact factor: 3.495

4.  Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.

Authors:  Khaled M Madbouly; Khaled S Abbas; Ahmed M Hussein
Journal:  Am J Surg       Date:  2013-10-08       Impact factor: 2.565

5.  Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting.

Authors:  Regina G H Beets-Tan; Doenja M J Lambregts; Monique Maas; Shandra Bipat; Brunella Barbaro; Filipe Caseiro-Alves; Luís Curvo-Semedo; Helen M Fenlon; Marc J Gollub; Sofia Gourtsoyianni; Steve Halligan; Christine Hoeffel; Seung Ho Kim; Andrea Laghi; Andrea Maier; Søren R Rafaelsen; Jaap Stoker; Stuart A Taylor; Michael R Torkzad; Lennart Blomqvist
Journal:  Eur Radiol       Date:  2013-06-07       Impact factor: 5.315

6.  Prognostic significance of extranodal microscopic foci discontinuous with primary lesion in rectal cancer.

Authors:  H Ueno; H Mochizuki; S Tamakuma
Journal:  Dis Colon Rectum       Date:  1998-01       Impact factor: 4.585

7.  Randomized, controlled trial of lateral node dissection vs. nerve-preserving resection in patients with rectal cancer after preoperative radiotherapy.

Authors:  H Nagawa; T Muto; K Sunouchi; Y Higuchi; G Tsurita; T Watanabe; T Sawada
Journal:  Dis Colon Rectum       Date:  2001-09       Impact factor: 4.585

8.  Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes?

Authors:  Max J Lahaye; Geerard L Beets; Sanne M E Engelen; Alfons G H Kessels; Adriaan P de Bruïne; Herry W S Kwee; Jos M A van Engelshoven; Cornelis J H van de Velde; Regina G H Beets-Tan
Journal:  Radiology       Date:  2009-04-29       Impact factor: 11.105

9.  Extended lymphadenectomy and preoperative radiotherapy for lower rectal cancers.

Authors:  Toshiaki Watanabe; Giichiro Tsurita; Tetsuichiro Muto; Toshio Sawada; Koki Sunouchi; Yoshiki Higuchi; Yasuhiro Komuro; Takamitsu Kanazawa; Takeru Iijima; Michiko Miyaki; Hirokazu Nagawa
Journal:  Surgery       Date:  2002-07       Impact factor: 3.982

10.  Nodal staging in rectal cancer: why is restaging after chemoradiation more accurate than primary nodal staging?

Authors:  Luc A Heijnen; Monique Maas; Regina G Beets-Tan; Myrthe Berkhof; Doenja M Lambregts; Patty J Nelemans; Robert Riedl; Geerard L Beets
Journal:  Int J Colorectal Dis       Date:  2016-04-07       Impact factor: 2.571

View more
  1 in total

1.  Clinical Robotic Surgery Association (India Chapter) and Indian rectal cancer expert group's practical consensus statements for surgical management of localized and locally advanced rectal cancer.

Authors:  S P Somashekhar; Avanish Saklani; Jagannath Dixit; Jagdish Kothari; Sandeep Nayak; O V Sudheer; Surender Dabas; Jagadishwar Goud; Venkatesh Munikrishnan; Pavan Sugoor; Prasanth Penumadu; C Ramachandra; Shilpa Mehendale; Akhil Dahiya
Journal:  Front Oncol       Date:  2022-10-04       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.